UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Buprenorphine STADA 5 mikrogram/timme depotplåster
- Scientific name part: Buprenorphine STADA
- Strength part: 5 mikrogram/timme
- Pharmaceutical dose form part: Depotplåster
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Transdermal patch
Legal status of supply: Medicinal product subject to special medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 52809
Region: Kingdom of Sweden
Marketing authorisation holder: STADA Arzneimittel AG
Identifier:
Status: Valid (2016-06-30)
Package 1 of 2
PCID:
Description: Påse, 12 x 1 plåster
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 12 Sachet (PolyEthylene TerePhthalate)
Containing: 1 Patch
Manufactured Item
Dose form: Transdermal patch
Unit of presentation: Patch
Ingredient
Role: Active
Substance: Buprenorphine
Presentation strength: 5 milligram(s) / 1 patch
Reference strength: Buprenorphine 5 milligram(s) / 1 patch
Package 2 of 2
PCID:
Description: Påse, 4 x 1 plåster
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 4 Sachet (PolyEthylene TerePhthalate)
Containing: 1 Patch
Manufactured Item
Dose form: Transdermal patch
Unit of presentation: Patch
Ingredient
Role: Active
Substance: Buprenorphine
Presentation strength: 5 milligram(s) / 1 patch
Reference strength: Buprenorphine 5 milligram(s) / 1 patch